Add time:08/30/2019         Source:sciencedirect.com

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin® for the treatment of respiratory tract infections..

We also recommend Trading Suppliers and Manufacturers of N-Methyl Gatifloxacin (cas 114213-69-3). Pls Click Website Link as below: cas 114213-69-3 suppliers